Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 107

1.

Alzheimer's disease susceptibility genes APOE and TOMM40, and hippocampal volumes in the Lothian birth cohort 1936.

Lyall DM, Royle NA, Harris SE, Bastin ME, Maniega SM, Murray C, Lutz MW, Saunders AM, Roses AD, del Valdés Hernández MC, Starr JM, Porteous DJ, Wardlaw JM, Deary IJ.

PLoS One. 2013 Nov 15;8(11):e80513. doi: 10.1371/journal.pone.0080513. eCollection 2013.

PMID:
24260406
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Alzheimer's disease susceptibility genes APOE and TOMM40, and brain white matter integrity in the Lothian Birth Cohort 1936.

Lyall DM, Harris SE, Bastin ME, Muñoz Maniega S, Murray C, Lutz MW, Saunders AM, Roses AD, Valdés Hernández Mdel C, Royle NA, Starr JM, Porteous DJ, Wardlaw JM, Deary IJ.

Neurobiol Aging. 2014 Jun;35(6):1513.e25-33. doi: 10.1016/j.neurobiolaging.2014.01.006. Epub 2014 Jan 8.

PMID:
24508314
[PubMed - in process]
Free PMC Article
3.

The effect of TOMM40 poly-T length on gray matter volume and cognition in middle-aged persons with APOE ε3/ε3 genotype.

Johnson SC, La Rue A, Hermann BP, Xu G, Koscik RL, Jonaitis EM, Bendlin BB, Hogan KJ, Roses AD, Saunders AM, Lutz MW, Asthana S, Green RC, Sager MA.

Alzheimers Dement. 2011 Jul;7(4):456-65. doi: 10.1016/j.jalz.2010.11.012.

PMID:
21784354
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Comprehensive search for Alzheimer disease susceptibility loci in the APOE region.

Jun G, Vardarajan BN, Buros J, Yu CE, Hawk MV, Dombroski BA, Crane PK, Larson EB; Alzheimer's Disease Genetics Consortium, Mayeux R, Haines JL, Lunetta KL, Pericak-Vance MA, Schellenberg GD, Farrer LA.

Arch Neurol. 2012 Oct;69(10):1270-9.

PMID:
22869155
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

TOMM40 intron 6 poly-T length, age at onset, and neuropathology of AD in individuals with APOE ε3/ε3.

Li G, Bekris LM, Leong L, Steinbart EJ, Shofer JB, Crane PK, Larson EB, Peskind ER, Bird TD, Yu CE.

Alzheimers Dement. 2013 Sep;9(5):554-61. doi: 10.1016/j.jalz.2012.06.009. Epub 2012 Nov 22.

PMID:
23183136
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Hippocampal atrophy and apolipoprotein E genotype are independently associated with Alzheimer's disease.

Jack CR Jr, Petersen RC, Xu YC, O'Brien PC, Waring SC, Tangalos EG, Smith GE, Ivnik RJ, Thibodeau SN, Kokmen E.

Ann Neurol. 1998 Mar;43(3):303-10. Review.

PMID:
9506546
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Longitudinal modeling of cognitive aging and the TOMM40 effect.

Caselli RJ, Dueck AC, Huentelman MJ, Lutz MW, Saunders AM, Reiman EM, Roses AD.

Alzheimers Dement. 2012 Nov;8(6):490-5. doi: 10.1016/j.jalz.2011.11.006.

PMID:
23102119
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

MRI of hippocampal volume loss in early Alzheimer's disease in relation to ApoE genotype and biomarkers.

Schuff N, Woerner N, Boreta L, Kornfield T, Shaw LM, Trojanowski JQ, Thompson PM, Jack CR Jr, Weiner MW; Alzheimer's Disease Neuroimaging Initiative.

Brain. 2009 Apr;132(Pt 4):1067-77. doi: 10.1093/brain/awp007. Epub 2009 Feb 27.

PMID:
19251758
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Apolipoprotein E epsilon 4 and the pattern of regional brain atrophy in Alzheimer's disease.

Hashimoto M, Yasuda M, Tanimukai S, Matsui M, Hirono N, Kazui H, Mori E.

Neurology. 2001 Oct 23;57(8):1461-6.

PMID:
11673590
[PubMed - indexed for MEDLINE]
10.

Polymorphism in the TOMM40 gene modifies the risk of developing sporadic inclusion body myositis and the age of onset of symptoms.

Mastaglia FL, Rojana-udomsart A, James I, Needham M, Day TJ, Kiers L, Corbett JA, Saunders AM, Lutz MW, Roses AD; Alzheimer’s Disease Neuroimaging Initiative.

Neuromuscul Disord. 2013 Dec;23(12):969-74. doi: 10.1016/j.nmd.2013.09.008. Epub 2013 Sep 19.

PMID:
24103330
[PubMed - indexed for MEDLINE]
11.

APOE E4 status predicts age-related cognitive decline in the ninth decade: longitudinal follow-up of the Lothian Birth Cohort 1921.

Schiepers OJ, Harris SE, Gow AJ, Pattie A, Brett CE, Starr JM, Deary IJ.

Mol Psychiatry. 2012 Mar;17(3):315-24. doi: 10.1038/mp.2010.137. Epub 2011 Jan 25.

PMID:
21263443
[PubMed - indexed for MEDLINE]
12.

Association and expression analyses with single-nucleotide polymorphisms in TOMM40 in Alzheimer disease.

Cruchaga C, Nowotny P, Kauwe JS, Ridge PG, Mayo K, Bertelsen S, Hinrichs A, Fagan AM, Holtzman DM, Morris JC, Goate AM; Alzheimer's Disease Neuroimaging Initiative.

Arch Neurol. 2011 Aug;68(8):1013-9. doi: 10.1001/archneurol.2011.155.

PMID:
21825236
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Reduced hippocampal volume in non-demented carriers of the apolipoprotein E epsilon4: relation to chronological age and recognition memory.

Lind J, Larsson A, Persson J, Ingvar M, Nilsson LG, Bäckman L, Adolfsson R, Cruts M, Sleegers K, Van Broeckhoven C, Nyberg L.

Neurosci Lett. 2006 Mar 20;396(1):23-7. Epub 2006 Jan 6.

PMID:
16406347
[PubMed - indexed for MEDLINE]
14.

TOMM40 polymorphisms in Italian Alzheimer's disease and frontotemporal dementia patients.

Bagnoli S, Piaceri I, Tedde A, Bessi V, Bracco L, Sorbi S, Nacmias B.

Neurol Sci. 2013 Jun;34(6):995-8. doi: 10.1007/s10072-013-1425-6. Epub 2013 Apr 2.

PMID:
23546992
[PubMed - indexed for MEDLINE]
15.

TOMM40 rs10524523 polymorphism's role in late-onset Alzheimer's disease and in longevity.

Maruszak A, Pepłońska B, Safranow K, Chodakowska-Żebrowska M, Barcikowska M, Zekanowski C.

J Alzheimers Dis. 2012;28(2):309-22. doi: 10.3233/JAD-2011-110743.

PMID:
22008263
[PubMed - indexed for MEDLINE]
16.

An inherited variable poly-T repeat genotype in TOMM40 in Alzheimer disease.

Roses AD.

Arch Neurol. 2010 May;67(5):536-41. doi: 10.1001/archneurol.2010.88. Review.

PMID:
20457951
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

APOE genotype, memory test performance, and the risk of Alzheimer's disease in the Canadian Study of Health and Aging.

Klages JD, Fisk JD, Rockwood K.

Dement Geriatr Cogn Disord. 2003;15(1):1-5.

PMID:
12457072
[PubMed - indexed for MEDLINE]
18.

Increased brain activation during working memory in cognitively intact adults with the APOE epsilon4 allele.

Wishart HA, Saykin AJ, Rabin LA, Santulli RB, Flashman LA, Guerin SJ, Mamourian AC, Belloni DR, Rhodes CH, McAllister TW.

Am J Psychiatry. 2006 Sep;163(9):1603-10.

PMID:
16946187
[PubMed - indexed for MEDLINE]
19.

Hippocampal atrophy as a quantitative trait in a genome-wide association study identifying novel susceptibility genes for Alzheimer's disease.

Potkin SG, Guffanti G, Lakatos A, Turner JA, Kruggel F, Fallon JH, Saykin AJ, Orro A, Lupoli S, Salvi E, Weiner M, Macciardi F; Alzheimer's Disease Neuroimaging Initiative.

PLoS One. 2009 Aug 7;4(8):e6501. doi: 10.1371/journal.pone.0006501.

PMID:
19668339
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Volumetric MRI vs clinical predictors of Alzheimer disease in mild cognitive impairment.

Fleisher AS, Sun S, Taylor C, Ward CP, Gamst AC, Petersen RC, Jack CR Jr, Aisen PS, Thal LJ.

Neurology. 2008 Jan 15;70(3):191-9. doi: 10.1212/01.wnl.0000287091.57376.65.

PMID:
18195264
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk